Difficult-to-control asthma: Clinical characteristics of steroid-insensitive asthma

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 5, 1998, Pages 594-601

  Chan, Mark T S ^a   Leung, Donald Y M ^a,b   Szefler, Stanley J ^a,b   Spahn, Joseph D ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Glucocorticoid; Inflammation; Steroid insensitive asthma; Steroid resistant asthma; Steroid sensitive asthma

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; HYDROCORTISONE; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; STEROID;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILDHOOD DISEASE; DISEASE SEVERITY; DRUG RESISTANCE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NEGRO; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEROID THERAPY;

ADOLESCENT; ASTHMA; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; PREDNISONE; RETROSPECTIVE STUDIES; SPIROMETRY; STEROIDS; TREATMENT OUTCOME;

EID: 0031981957     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70165-4     Document Type: Article

References (24)

1. Spahn JD, Kamada AK, Szefler SJ. Glucocorticoid therapy in asthma. In: Lieberman P, Anderson JA, editors. Allergic diseases: Diagnosis and treatment. Totowa, N.J.: Humana Press Inc; 1997. p. 331-50.
2. Schwarte HJ, Lowell FC, Melby JC. Steroid resistance in bronchial asthma. Ann Intern Med 1968;69:493-9.
3. Turner-Warwick M. On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest 1977;71:73-86.
4. Carmichael J, Paterson IC, Diaz P, Crompton OK, Kay AB, Grant IWB. Corticosteroid resistance in chronic asthma. Br Med J 1981;282:1419-22.
5. Lee T, Brattsand R, Leung DYM. Corticosteroid action and resistance in asthma. Am J Respir Crit Care Med 1996;154:S1-79.
6. Riche MF. How America is changing: the view from the Census Bureau, 1995. The World Almanac and Book of Facts-1996. Mahweh (NJ): St. Martin's Press; 1996. p. 382.
7. Zimmerman B, Feanny S, Reisman J, Hak H, Rashed N, McLaughlin FJ, Levison H. Allergy in asthma, I: the dose-response relationship of allergy to severity of childhood asthma. J Allergy Clin Immunol 1988;81:63-70.
8. Montgomery Smith J. Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis. In: Middleton E, Reed C, Ellis E, Adkinson N, Yunginger J, editors. Allergy: Principles and practice. 3rd ed. St. Louis: CV Mosby Company; 1988. p. 891-929.
9. Tuchinda M, Habanananda S, Vareenil J, Srimaruta N, Piromrat K. Asthma in Thai children: a study of 2000 cases. Ann Allergy 1987;59:207-11.
10. Sher ER, Leung DYM, Surs W, Kam JC, Zieg G, Kamada AK, et al. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994;93:33-9.
11. Walker KB, Potter JM, House AK. Interleukin 2 synthesis in the presence of steroids: a model of steroid resistance. Clin Exp Immunol 1987;68:162-7.
12. Poznansky M, Gordon ACH, Douglas JG, Krajewski AS, Wyllie AH, Grant IW. Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid resistant asthmatic patients. Clin Sci 1984;67:639-45.
13. Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai J-J, Frew AJ, et al. Glucocorticoid resistance in chronic asthma glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991;144:1016-25.
14. Alvarez J, Surs W, Leung DYM, Iklé D, Gelfand EW, Szefler SJ. Steroid-resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol 1992;89:714-21.
15. Corrigan CJ, Brown PH, Barnes NC, Tsai J-J, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma: peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 1991;144:1026-32.
16. Dunnill MS, Massarella GR, Anderson JA. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis and in emphysema. Thorax 1969;24:176-9.
17. Roche WR, Williams JH, Beasley R, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;1:520-4.
18. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 131:599-606.
19. Jeffrey PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-53.
20. Boggs PB. Peak expiratory flow rate control chart: a breakthrough in asthma care [editorial]. Ann Allergy Asthma Immunol 1996;77:429-33.
21. Chung KF. Role of inflammation in the hyper-reactivity of the airways in asthma. Thorax 1986;41:657-62.
22. Sly RM, O'Donnell R. Stabilization of asthma mortality. Ann Allergy Asthma Immunol 1997;78:347-54.
23. Rosenstreich DL, Eggleston P, Kattan M, Baker D, Slavin RG, Gergen P, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 1997;336:1356-63.
24. Gainer JV, Nadeau JH, Ryder D, Brown NJ. Increased sensitivity to bradykinin among African Americans. J Allergy Clin Immunol 1996;98:283-7.